Near infrared (NIR) light is generally safe at the power levels used in consumer devices and clinical therapy. It is a form of non-ionizing radiation, meaning it does not carry enough energy to damage DNA the way ultraviolet light or X-rays can. The primary risk from NIR is thermal: at high enough intensities, it heats tissue. At the low intensities found in most home-use panels and clinical settings, this heating is negligible, and no serious side effects have been documented in controlled studies.
How NIR Differs From Harmful Radiation
Near infrared light sits just beyond the visible red end of the spectrum, in the range of roughly 700 to 1400 nanometers. Unlike ultraviolet radiation, which triggers photochemical damage to DNA and causes sunburns and skin cancer, NIR works through entirely different pathways. It is classified as non-ionizing, placing it in the same broad safety category as visible light and radio waves.
At the cellular level, NIR interacts with two main targets: an enzyme in your mitochondria called cytochrome c oxidase, and structured water layers inside cells. When NIR photons hit cytochrome c oxidase, the enzyme speeds up its normal job of producing ATP, which is the energy currency your cells run on. This also generates a brief pulse of reactive oxygen species, which at low levels act as signaling molecules rather than causing damage. At certain wavelengths (around 980 nm), NIR instead works by subtly shifting the structure of water molecules inside ion channels in cell membranes, which can influence calcium signaling without any measurable rise in temperature. These are fundamentally different mechanisms from what UV light does, and they activate different gene pathways in skin cells.
The Intensity Threshold That Matters
Safety with NIR comes down to power density, measured in milliwatts per square centimeter (mW/cm²). Research on NIR applied to skin found that tissue damage begins when skin temperature rises above 50°C. In controlled experiments, delivering light at 150 mW/cm² raised skin temperature by less than 1°C. At 300 mW/cm², the increase was about 4°C. At 600 mW/cm², it climbed roughly 11°C, and burn injuries started appearing at power densities above that level.
Clinical trials typically cap NIR exposure at 150 mW/cm² or below. Most consumer LED panels and wearable masks operate at around 10 mW/cm², which is a fraction of what would cause any thermal concern. At that level, the light produces its cellular effects without any meaningful heating of tissue.
Eye Safety Requires Attention
Your eyes are the most vulnerable part of your body when it comes to NIR exposure. The cornea, lens, and retina can all absorb near infrared energy between 780 and 1400 nm, and because NIR is invisible, your pupils won’t constrict the way they would in bright visible light. This means your natural protective reflexes don’t kick in.
The International Electrotechnical Commission sets specific limits for eye exposure: for sessions longer than about 17 minutes, the infrared irradiance reaching your eyes should stay below 100 watts per square meter (10 mW/cm²). Devices are classified into risk groups based on how quickly they could exceed retinal safety thresholds. Devices that stay within limits for over 1000 seconds of continuous exposure earn an “exempt” classification, while those exceeding limits within 10 seconds fall into the moderate or high risk categories.
The real-world concern is cumulative occupational exposure. Studies of glassblowers and metalworkers exposed to infrared radiation at 80 to 400 mW/cm² on a daily basis developed lens clouding (cataracts) after 10 to 15 years. Acute lens damage requires much higher energy, on the order of 4 W/cm² sustained for an hour. Consumer NIR devices operate far below these thresholds, but wearing the protective goggles that come with most panels is still a sensible precaution, especially for direct facial treatments.
What Four Weeks of Daily Use Looks Like
A double-blind, placebo-controlled study exposed healthy adults to 850 nm NIR light five days a week for four consecutive weeks, testing three different doses. Participants used the devices at home for several hours per day. Side effects were minimal: a small number of people (between one and three across the entire study) reported headaches, eyestrain, dizziness, tiredness, or dry skin. These complaints did not correlate with the NIR dose, suggesting they were likely unrelated to the light itself. The study found improvements in several well-being and health measures at the highest dose tested, and these benefits held up over the full treatment period.
That said, long-term safety data spanning years of daily use does not yet exist. The Cleveland Clinic notes that short-term use appears safe when devices are used as directed, but the effects of years of consistent exposure remain unstudied.
How Consumer Devices Are Regulated
The FDA classifies light-based devices that emit near infrared energy for topical application as Class II medical devices, which is a moderate-risk category that requires special controls. To earn clearance, manufacturers must characterize the device’s wavelength, power, energy density, and treatment time. They must also validate electromagnetic compatibility, ocular safety, electrical safety, and biocompatibility. Clinical data demonstrating both effectiveness and an acceptable risk profile for burns, blisters, redness, and discomfort is required.
Many consumer NIR panels sold for general wellness, however, are marketed without going through this process. They avoid FDA scrutiny by not making specific medical claims. This does not necessarily make them dangerous, since the power levels involved (often around 10 mW/cm²) are well within safe ranges. But it does mean the manufacturer has not been required to submit safety testing data to a regulatory body. Looking for devices that list their power density, wavelength, and compliance with the IEC 62471 photobiological safety standard gives you a reasonable baseline for confidence.
Situations That Call for Caution
NIR light at therapeutic doses has not been shown to cause harm in most people, but a few situations warrant extra care. Applying NIR directly over areas with active cancer is generally avoided in clinical practice, since the light stimulates cellular metabolism and blood flow, and the theoretical concern is that this could promote tumor growth. No human studies have confirmed this risk, but the precaution is standard.
Photosensitizing medications, which make your skin more reactive to light, could potentially amplify the effects of NIR exposure. If you take medications that list sun sensitivity as a side effect, it is worth checking with a pharmacist before starting regular NIR sessions. Pregnant women are also typically excluded from clinical NIR studies as a precaution, not because of documented harm, but because safety data in pregnancy simply does not exist.
The most practical risk for everyday users is misuse: holding a device too close for too long, skipping eye protection, or using a high-powered device without understanding its output. Following the manufacturer’s recommended distance and session length keeps exposure well within established safety margins.